Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPC Silver Wound Gel (EPC-123) Feasibility Clinical Study: Prospective, Single-arm, Repeated Measures Study of EPC Silver Wound Gel in the Management of Locally Infected Diabetic Foot Ulcers

NCT05243810 is registered in ClinicalTrials.gov with Exciton Technologies Inc. as lead sponsor.

NCT NCT05243810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPC Silver Wound Gel (EPC-123) Feasibility Clinical Study: Prospective, Single-arm, Repeated Measures Study of EPC Silver Wound Gel in the Management of Locally Infected Diabetic Foot Ulcers
Lead sponsor
Exciton Technologies Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 28, 2022
Completion date
September 21, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot infection, diabetic foot ulcer, non-healing diabetic foot ulcer